Paris, France

Anne-Geneviève Marcelin

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Anne-Geneviève Marcelin

Introduction

Anne-Geneviève Marcelin is an accomplished inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, specifically focusing on innovations related to anti-inflammatory treatments. With a total of five patents to his name, Marcelin's work is paving the way for advancements in medical therapies.

Latest Patents

Among his notable inventions are derivatives of Meclozine and Diclazuril, aimed at the prevention and treatment of disorders associated with inflammation. These compounds, represented by specific general formulas, are particularly beneficial in addressing conditions such as acne, psoriasis, chronic urticaria, urticaria pigmentosa, cutaneous autoinflammatory diseases, hidradenitis, and atopic dermatitis. His recent patents demonstrate a strong commitment to developing pharmaceutical solutions that enhance patient care and quality of life.

Career Highlights

Throughout his career, Marcelin has worked with reputable institutions, notably Assistance Publique-Hôpitaux de Paris and Université de Paris. His associations with these organizations have reinforced his expertise and provided a platform for collaborative research and innovation. His contributions to these institutions reflect a dedication to advancing healthcare through scientific research and patentable inventions.

Collaborations

Marcelin has worked alongside esteemed colleagues, including Vincent Calvez and Nicolas Dupin. Their collaborative efforts have been instrumental in driving forward research initiatives that seek to bring revolutionary treatments to the forefront of medicine. The synergy among these professionals has fostered an environment conducive to impactful innovations.

Conclusion

In conclusion, Anne-Geneviève Marcelin stands out as a prominent inventor whose work in the field of anti-inflammatory pharmaceuticals is both innovative and essential. With several patents to his credit and a background enriched by collaboration with esteemed institutions and individuals, Marcelin's contributions have the potential to significantly improve treatment options for patients suffering from various inflammatory disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…